Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 21.2% on Thursday . The stock traded as high as C$0.20 and last traded at C$0.20. Approximately 216,394 shares traded hands during mid-day trading, a decline of 60% from the average daily volume of 534,421 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The company’s 50-day moving average is C$0.10 and its two-hundred day moving average is C$0.07. The stock has a market capitalization of C$27.89 million, a P/E ratio of -20.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Start Investing in Real Estate
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- How to Invest in Biotech Stocks
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Comparing and Trading High PE Ratio Stocks
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
